Hims & Hers Health is trading 7.02% up at €24.40 on November 4, 2026, with a broader healthcare-sector rally following the midterm results the likeliest support; no clear company-specific catalyst was identified. - Recent company coverage has focused on securities-class-action notices. - Third-quarter results are scheduled for November 9; neither item establishes a direct cause for today’s rise. - The supplied price context is used for the quoted price and percentage.